VBY-825 is primarily utilized in the field of medical research, particularly in the development of treatments for neurological disorders. Its application is focused on targeting specific pathways involved in neurodegenerative diseases, such as Alzheimer's and Parkinson's. Researchers are exploring its potential to modulate protein misfolding and aggregation, which are key factors in the progression of these conditions. Additionally, VBY-825 is being investigated for its role in enhancing cognitive function and protecting neuronal cells from damage. Its use in preclinical studies has shown promise in improving outcomes in animal models, paving the way for further clinical trials to assess its efficacy and safety in humans.